Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story stocks' without revenue, let alone profit. And in their study titled Who Falls Prey ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Shares ofBioTelemetry(NASDAQ: BEAT), a medical device company focused primarily on mobile cardiac monitoring, are up more than 16% as of 11:45 a.m. EDT on Wednesday. The huge jump is attributable to ...
Philips announced this past week that it will acquire BioTelemetry, a provider of remote cardiac diagnostics and monitoring, for $2.8 billion. The transaction is expected to be completed in the first ...
BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics firm will be acquired by Dutch company Royal Philips for $2.8 billion. BioTelemetry is a Pennsylvania-based medical ...
BioTelemetry (BEAT) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.52 per share a year ago. These figures ...
Researchers are the first to characterize the ecology and fine-scale habitat use of 'near threatened' whitespotted eagle rays in Florida while also identifying areas of potential interactions between ...
BioTelemetry, formerly known as CardioNet, has acquired TelCare, a diabetes management technology company with the distinction of having had the first FDA-cleared, cellular-connected glucometer.
Scaling down electronics isn't only important when building consumer devices, it also has a hufe impact on the world of implantable medical devices. However, as with all things technological, ...
Two nationally recognized healthcare companies settled separate multimillion dollar claims tied to False Claims Act (FCA) violations, highlighting the continued scrutiny that providers face from ...
BIOTELEMETRY ($BEAT) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.18 per share, beating estimates of -$0.19 by $0. ...
Shares jump on the news that a major insurance company has decided to offer coverage on mobile cardiac telemetry devices. BioTelemetry is on a roll this year. The company's revenue and profits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results